Ligand Pharmaceuticals | LGND - 股票

股票价格

213.44

每天变化

8.52 4.16%

每月一次

2.71%

每年

100.24%

Q2 预测

199.33

金融业

USD

USD 1.56B

现金及等价物

USD 174.93M

USD 11.9M

USD 832.27M

USD 37.45M

USD 451M

USD 158.89M

USD 150.32M

68

EPS每股收益

USD 2.02

股本和储备

USD 1.02B

USD 155.28M

债务利息支出

USD 910K

USD 3.87M

USD 445.49M

USD 3.63B

USD 117.27M

USD 8.29M

USD 158.89M

普通股股本

USD 19.66M

60.65

USD 141.14M

USD 59.66M

销售和管理费用

USD 28.45M

USD 9.13M

贸易债权人

USD 3.24M

应收帐款人

USD 58.1M

	股票	更改		日
Amgen	USD 6.22B		121M	2025-12
Anika Therapeutics	USD 18.79M		2.5M	2025-12
Arrowhead Research	USD -173.08M		173.08M	2024-12
Baxter International	USD 2.23B		228M	2025-12
Bristol-Myers Squibb	USD 2.76B		21M	2025-09
Eli Lilly	USD 13.74B		1.56B	2025-12
Enviri Corporation	USD 195.42M		360K	2025-09
Gilead Sciences	USD 1.78B		40M	2025-09
GlaxoSmithKline	GBP 6.12B		46M	2025-09
Glaxosmithkline	GBP 6.12B		46M	2025-09
Heron Therapeutics	USD 54.57M		2.33M	2022-12
Insmed	USD 132.07M		11.1M	2025-12
Intrexon	USD 287K		68K	2022-12
Ionis Pharmaceuticals	USD 10.47M		1.99M	2025-09
Karyopharm Therapeutics	USD 4.04M		72K	2025-12
Ligand Pharmaceuticals	USD 9.13M		2.77M	2025-12
MacroGenics	USD 7.91M		840K	2025-12
Merck	USD 6.44B		157M	2025-09
Pacira	USD 152.86M		4.82M	2025-12
Pfizer	USD 11.47B		201M	2025-09
Rigel Pharmaceuticals	USD 13.3M		2.88M	2025-09
Veracyte	USD 20.55M		219K	2025-12